alector.com (ALEC) Narxning foydaga nisbati
Alector, Inc. (ALEC) kompaniyasining neyrodori ishlab chiqish jarayoni xalqaro savdo mojarolari va transchegaraviy logistika muammolari tufayli murakkablashgan. Yuqori R&D xarajatlari hamda demensiyani davolash vositalarining yakuniy sinov natijalari kutilayotgani sababli, biznes hozirda xavf zonasida qolmoqda. GURU.Markets platformasidagi narxlar dinamikasi 6.80 qiymatini aks ettirmoqda, shu bilan birga kompaniya energiya tejamkor tizimlarni joriy etish va bio-chiqindilarni xavfsiz qayta ishlash orqali ESG standartlariga qat'iy rioya qilmoqda.
Alector, Inc. kompaniyasining tahliliy kesimlari
- narx va narxlar bo'yicha konsensus prognoz:
- bozor kapitallashuvi tafsilotlari:
- balans kapitallashuvi haqida ma'lumot:
- qarzlar va to'lov qobiliyati haqida ma'lumot:
Jamlagan qarzning kapitalga nisbati Alector, Inc.|ALEC - Uzoq muddatli qarzning o'z kapitaliga nisbati|Qisqa muddatli majburiyatlarning kapitalga nisbati Alector Therapeutics|ALEC - Kompaniya qarzlari|Qarzning sof aktivlarga nisbati Alector, Inc.|ALEC - Kompaniyaning uzoq muddatli majburiyatlari|Kompaniyaning qisqa muddatli kredit va qarzlari Alector|Oraliq qoplama koeffitsiyenti alector.com
- biznes foydasi va investitsiya koeffitsiyentlari ma'lumotlari:
ALEC - Kompaniyaning sof foydasi|Sof foyda prognozi Alector, Inc.|ALEC - P/E multiplikatori|Prognoz qilingan narxning foydaga nisbati Alector Therapeutics|ALEC - Narx-foyda va o‘sish multiplikatori|Kompaniyaning to‘liq qiymatining amortizatsiyadan oldingi operatsion foydaga nisbati Alector, Inc.|ALEC - EBITDA operatsion foydasi|Bir aksiya uchun sof foyda (EPS TTM) Alector|ALEC - So'nggi o'n ikki oy davomida bir aksiya uchun foyda|So'nggi o'n ikki oy davomida bir aksiya uchun foydaning yillik o'sishi alector.com|ALEC - Joriy yilda foyda o'sishi|Keyingi yilda bir aksiya uchun sof foydaning kutilayotgan o'sishi Alector, Inc.
Kompaniyaning har tomonlama tahlili:alector.com - ALEC
Fundamental xatarlarni minimallashtirish uchun investorlar generatsiya qilingan daromadga nisbatan isbotlangan qiymatga ega aktivlarni tanlaydilar. P/E koeffitsiyenti bir aksiya bozor narxining sof foydaga bo'linishini aks ettiradi va investitsiyaning qoplanish muddatini ko'rsatadi. Robotlashtirilgan antitelalarni skrining qilishni kengaytirayotgan Alector, Inc. (ALEC) uchun ushbu hisob-kitob texnologik qiymatni haqiqiy operatsion samaradorlikka bog'laydi. Kompaniyaning P/E vaqtlar ketma-ketligini tahlil qilish texnologik transformatsiya davrida tendentsiya nuqtalarining o'zgarishini aniqlash imkonini beradi.
Raqobatdosh kompaniyalar
P/E multiplikatori biogen.com|Narxning foydaga nisbati Neurocrine Biosciences, Inc. (NBIX)|Narxning foydaga nisbati RGC (Regencell Bioscience Ltd)|P/E multiplikatori AXSM (Axsome Therapeutics Inc)|ACADIA Corp (ACAD) - Kapitalizatsiyaning foydaga nisbati|Xenon Pharmaceuticals - P/E multiplikatori|vikingtherapeutics.com (VKTX) - Narx-foyda koeffitsiyenti|SUPN (Supernus) - Narx-foyda koeffitsiyenti|CPRX: Bozor narxining sof foydaga nisbati|Narxning foydaga nisbati Denali Therapeutics Inc|Kapitalizatsiyaning foydaga nisbati Harmony Corp HRMY|Narxning foydaga nisbati Biohaven Ltd. (BHVN)|AMLX (amylyx.com) - Kompaniya qiymatining sof foydaga nisbati|Trevi Therapeutics, Inc. - Narx-foyda koeffitsiyenti|Kompaniya qiymatining sof foydaga nisbati PRAX|Anavex Corp - P/E multiplikatori|Biznesning o‘zini qoplash muddati CeriBell EEG CBLL|prothena.com (PRTA) - Narxning foydaga nisbati|Narx-foyda multiplikatori ANNX|OMER (Omeros Corp) - P/E multiplikatori|Narx-foyda koeffitsiyenti Neurogene Inc (NGNE)|Narx-foyda koeffitsiyenti ACIU (AC Immune Corp)|Biznesning o‘zini qoplash muddati Voyager Corp|P/E multiplikatori NMRA (Neumora Therapeutics)|P/E multiplikatori scilexholding.com SCLX|TVGN - Narxning foydaga nisbati|ACOG: Narxning foydaga nisbati|CGTX: P/E multiplikatori|Kapitalizatsiyaning foydaga nisbati Inhibikase Pharma (IKT)|SAVA (Cassava Sciences, Inc.) - P/E multiplikatori|Narx-foyda koeffitsiyenti Assertio Therapeutics (ASRT)|Narxning foydaga nisbati Coya Therapeutics, Inc. (COYA)|vistagen.com - Narx-foyda multiplikatori|P/E multiplikatori OVID (Ovid Therapeutics)|Acumen Pharmaceuticals, Inc (ABOS) - Kapitalizatsiyaning foydaga nisbati|CRVO: Narx-foyda koeffitsiyenti|ATHE - P/E multiplikatori|clene.com (CLNN) - Narxning foydaga nisbati|PepGen - Kompaniya qiymatining sof foydaga nisbati|Narxning foydaga nisbati Jupiter Neurosciences|Kapitalizatsiyaning foydaga nisbati Relmada Corp RLMD|P/E multiplikatori ANVS|P/E multiplikatori gracetx.com (GRCE)|Narxning foydaga nisbati Firefly Neuroscience AIFF|ANEW Medical - Narxning foydaga nisbati|NeuroSense Therapeutics, Ltd. - P/E multiplikatori|Kapitalizatsiyaning foydaga nisbati Reviva Pharmaceuticals, Inc.|MTVA: P/E multiplikatori|Narx-foyda koeffitsiyenti neuraxis.com|Narx-foyda koeffitsiyenti HSDT|PASG (Passage Bio Corp) - Bozor narxining sof foydaga nisbati|Narxning foydaga nisbati Neuphoria Therapeutics Inc. (NEUP)|NERV - Kapitalizatsiyaning foydaga nisbati|Narxning foydaga nisbati Athira Pharma, Inc. ATHA|Kompaniya qiymatining sof foydaga nisbati ADXN|ALZN: Narx-foyda koeffitsiyenti|Kompaniya qiymatining sof foydaga nisbati CYCN (Cyclerion Therapeutics)|PTIX: P/E multiplikatori|KTTA - Biznesning o‘zini qoplash muddati|Narxning foydaga nisbati Cortigent Inc|Narx-foyda multiplikatori ATXI (avenuetx.com)|P/E multiplikatori BCLI|Narx-foyda koeffitsiyenti Cara Therapeutics Inc. CARA|Chromocell Therapeutics Corporation - Narx-foyda koeffitsiyenti|Biznesning o‘zini qoplash muddati Eliem Therapeutics, Inc. (ELYM)|Intra-Cellular - P/E multiplikatori|LBPH - P/E multiplikatori|Marinus Pharmaceuticals, Inc. (MRNS) - Narxning foydaga nisbati|NKGN (NKGen Biotech Inc) - Narxning foydaga nisbati|NRBO (NeuroBo) - P/E multiplikatori|Kapitalizatsiyaning foydaga nisbati Sage Therapeutics Inc SAGE|P/E multiplikatori SNPX|Narx-foyda koeffitsiyenti trevena.com TRVN|Narxning foydaga nisbati Vigil Neuroscience, Inc. VIGL|WENA: Narx-foyda multiplikatori|Cerevel - P/E multiplikatori
